Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of oxyresveratrol cream in healthy volunteers and patients with dermatitis
TCTR20240611001Phase 3
Key facts
- Status
- Completed
- Start
- Jul 2024
- Countries
- 1
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Modality
- Small Molecules
- Drugs
- oxyresveratrol
- Conditions
- dermatitis
01
Overview
Phase 3 trial of oxyresveratrol in dermatitis, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jul 2024; status: completed.
02
Who it enrols
Adults including both healthy volunteers and patients diagnosed with dermatitis.
Beyond the preview
Go deeper on TCTR20240611001.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240611001.